In order to identify proteins that interacted with Bmh2, a yeast member of the 14-3-3 protein family, we performed a two-hybrid screening using LexA-Bmh2 as bait. We identified Fin1, a novel intermediate filament protein, as the protein that showed the highest degree of interaction. We also identified components of the vesicular transport machinery such as Gic2 and Msb3, proteins involved in transcriptional regulation such as Mbf1, Gcr2 and Reg2, and a variety of other different proteins (Ppt1, Lre1, Rps0A and Ylr177w). We studied the interaction between Bmh2 and Fin1 in more detail and found that Bmh2 only interacted with phosphorylated forms of Fin1. In addition, we showed that Glc7, the catalytic subunit of the PP1 phosphatase complex, was also able to interact with Fin1.
INTRODUCTION

4
Σ1278 bmh1bmh2∆ (a bmh1∆::HIS3 bmh2∆::HIS3 derivative of Σ1278b) [10] were from Dr. G. Fink (Whitehead Institute for Medical Research, MIT, Cambridge, USA). Strain glc7-1 was from Dr. Kelly Tatchell (Louisiana State University Medical Center, Shreveport, USA). Strains CTY10-5d (MATa ade2 his3 leu2 trp1 gal4 gal80 URA3::lexAop-lacZ) and TAT-7 (MATa ade2 his3 leu2 trp1 gal4 gal80 LYS2::lexAop-HIS3 URA3::lexAop-lacZ) were a gift from Dr. R. Sternglanz (State University of New York, Stony Brook, USA).
Standard methods for genetic analysis and transformation were used. Yeast cultures were grown in synthetic complete (SC) medium lacking appropriate supplements to maintain selection for plasmids [20] , supplemented with different carbon sources.
2.-
Plasmids. Oligonucleotides BMH2-1: 5'-CCGGGATCCCAAAAAAAAATGTCCCAAACTC-3' (the initial ATG is underlined) and BMH2-2: 5'-CCCCTCGAGTTTGTCGACGCTCTTATTTGGTTGG-3' (the stop codon is underlined) were used to amplify by PCR the coding region of the BMH2 gene using genomic DNA of FY250 as template; the amplified fragment was digested with BamHI and SalI and subcloned into pBTM116 [21] to obtain pBTM-Bmh2. (LexA-Bmh2, TRP1). The same fragment was subcloned into pEG-GST (a derivative of pEG202 [22] where the LexA gene has been substituted by the glutathione S-transferase gene from Schistosoma japonicum] to obtain pGST-Bmh2 (GST-Bmh2, HIS3). Oligonucleotides FIN1-1: 5'-CAAGGATCCAAATTATGAGCAATAAAAGCAACC-3' (the initial ATG is underlined) and FIN1-2: 5'-AAGGGTCGACATTACTTATGTTTCGGTATTTCC-3' (the stop codon is underlined) were used to amplify by PCR the coding region of the FIN1 gene using genomic DNA of FY250 as template; the amplified fragment was digested with BamHI and SalI and subcloned into pEG202 [22] to obtain pEG202-Fin1 (LexA-Fin1, HIS3). The same fragment was introduced in pACTII [23] and pWS93 [24] to obtain pACTII-Fin1 (GADFin1, LEU2) and pWS-Fin1 (HA-Fin1, URA3), respectively.
To construct pGST-Glc7 (GST-Glc7, HIS3), a fragment from pHA-Glc7 [25] was introduced in pEG-GST (see above). In some experiments we also used pGAD-Glc7 [25] .
3.-Two-hybrid screening. A two-hybrid screening [26] for proteins that interacted with LexA-Bmh2 (pBTM-Bmh2, see above) was carried out in strain TAT-7 which contained two chromosomally located reporter genes, lexAop-HIS3 and lexAop-lacZ [27] . The strain was transformed with a library of S. cerevisiae cDNAs fused to the activation domain of Gal4 (GAD; generous gift of Dr. S. Elledge, Baylor University, USA; [28] ). Transformants were selected in SC+2%glucose plates containing 10 mM 3-amino-1,2,4 triazole (3-ATA) and were subsequently screened for β-galactosidase activity using a filter lift assay [29] . Positive transformants were grown in plates containing increasing concentrations of 3-ATA (from 20 to 120 mM) to have an estimation of the strength of the interaction.
4.-β β-Galactosidase assays. β-Galactosidase activity was assayed in permeabilized cells and expressed in Miller units as in [30] .
5.-λ λ-Phosphatase treatment. Preparation of crude extracts was essentially as described previously [31] . The extraction buffer was 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, 1 mM dithiothreitol, 10% glycerol and contained 2 mM Mannheim) . Crude extracts (2 µg) in λ-phosphatase buffer containing 2 mM MnCl 2 were treated at 30°C for 30 min with 50 or 100 Units of λ-phosphatase (New England BioLabs) in the presence or absence of a mixture of phosphatase inhibitors (50 mM EDTA, 50 mM NaF, 100 mM sodium phosphate buffer, pH 8). The reactions were stopped by adding one volume of sample buffer and boiling for 3 min.
6.-Pull-down assay. Crude extracts prepared as above were used in the pull-down assays and combined with GSH-agarose (Amersham) as in [31] . Proteins in the pellet were analysed by Western blotting using anti-HA monoclonal antibodies.
7.-Immunoblot analysis. Protein samples were separated by SDS-PAGE using 10% polyacrylamide gels and analysed by immunoblotting using either anti-GST (Amersham) polyclonal or anti-HA (Boehringer Mannheim) monoclonal antibodies. Antibodies were detected by enhanced chemiluminiscence with ECL or ECL Plus reagents (Amersham).
RESULTS AND DISCUSSION
1.-Identification of proteins that interacted with Bmh2.
In Saccharomyces cerevisiae, the members of the 14-3-3 protein family participate in the regulation of different physiological processes (see Introduction). In order to identify additional interacting proteins that may affect any of these processes, we performed a twohybrid screening using LexA-Bmh2 as bait (see Materials and Methods). After screening 10 6 transformants, we were able to recover more than 300 putative positive transformants that were able to grow in the absence of histidine and were blue in the β-galactosidase filter assay. In this study we describe the characterization of the inserts contained in 50 of these transformants, which showed the highest degree of interaction (measured as the capacity to grow in the presence of increasing concentrations of 3-amino-1,2,4-triazole). The plasmids contained in these selected transformants were recovered, the corresponding inserts sequenced and the identity of the respective genes determined by BLAST analysis [32] .
As a result of this screening (Table I) we identified components of the vesicular transport machinery, as Gic2 (a GTPase-associated protein required for polarized cell growth [33] ) and Msb3 (a GTPase-activating protein involved in bud emergence [34] ), consistent with the participation of Bmh2 in this process [7] . Bmh2 was also able to interact with proteins involved in transcriptional regulation, as Mbf1 (a transcriptional coactivator of Gcn4 [35] ), Gcr2 (a transcriptional activator involved in the regulation of glycolytic gene expression [36] ) and Reg2 (a Glc7 protein phosphatase regulatory subunit [37] ), and with a variety of other different proteins, such as Ppt1 (a Ser/Thr protein phosphatase of unknown function, member of the PP5 phosphatase family [38] ), Lre1 (a protein involved in cell wall maintenance [39] ), Rps0A (a ribosomal protein S0 [40] ) and Ylr177w (a protein of unknown function [19] ) (Table I ). Bmh2 interacted also with itself and with Bmh1, the other Saccharomyces cerevisiae member of the 14-3-3 protein family, confirming the dimeric nature of these proteins and indicating that they may form both homo and heterodimers (Table I) .
However, the clone that was recovered more frequently (26 isolates out of 50) corresponded to in frame fusions of cDNAs of the FIN1 gene, that started at different positions either at the 5' untranslated or inside the coding region of the gene. In addition, transformants containing FIN1 derivatives were the ones that presented the highest levels of interaction with Bmh2 (β-galactosidase activity) (Table I ). For this reason we focused our attention on the study of the interaction between Bmh2 and Fin1.
2.-Bmh2 interacts only with phosphorylated Fin1.
FIN1 (YDR130c) is a gene encoding a protein of 291 aa (33,070 daltons of molecular mass). Although the exact cellular role of Fin1 is still unknown, it has been described in the Yeast Proteome (YPD; [19] ) and in the Saccharomyces Genome (SGD; [41] ) databases as a novel intermediate filament protein that might play a role in cell-cycle regulation. In fact, it has been recently described that the expression of FIN1 is induced during the S/G2 phase of the cell cycle [42] , although its deletion has no observable phenotypes [43] .
Intermediate filament proteins (IF) are a family of heterogeneous proteins in size and amino acid sequence that share in common a typical structural organization. All the intermediate filament proteins have a central α-helical rod domain flanked by nonhelical amino-and carboxy-terminal domains that varied depending on the particular IF. The α-helical rod domain plays a central role in dimerization, where the two polypeptide chains are wound around each other in a coiled-coil structure. The dimers then associate in a staggered antiparallel fashion to form tetramers, which can assemble end to end to form protofilaments ( [44] , [45] ). Phosphorylation of the intermediate filament proteins is a major regulator of IF assembly; phosphorylation of IF results in their disassembly, whereas phosphatase treatment of phosphorylated subunits restores their competence for assembly (see [44] and [45] for a review).
Fin1 has the characteristic IF α-helical rod domain that might participate in dimerization (Fig. 1) . In fact, by two-hybrid analysis we detected that Fin1 (LexA-Fin1) was able to interact with itself (GAD-Fin1) forming stable complexes (Table II) . In addition, we observed that Fin1 was present in the crude extracts as a mixture of phosphorylated and unphosphorylated forms; an N-terminal hemagglutinin A (HA)-tag derivative of Fin1 (HA-Fin1; see Materials and Methods) appeared in the crude extracts as a doublet, the upper band being sensitive to treatment with exogenous λ-phosphatase ( Fig.  2A) .
In order to study the interaction between Bmh2 and Fin1, we amplified by PCR the coding region of FIN1, which was sequenced to confirm that no modifications had been introduced by the Taq polymerase. This amplified fragment was used to construct LexAFin1 and GAD-Fin1 derivatives (see Materials and Methods). As shown in Table II , LexABmh2 interacted strongly with GAD-Fin1. The physical interaction between Bmh2 and Fin1 was confirmed by pull-down assays. In wild type cells expressing GST-Bmh2 and HA-Fin1 as fusion proteins, we observed a specific interaction between Bmh2 and Fin1 (Fig. 2B) . This interaction was only observed with the upper, phosphorylated forms of HA- [47] ). Also in a survey to identify cellular polypeptides that interacted with the 14-3-3ζ protein in vivo, vimentin (a member of the IF family) was found to be the most abundant protein that interacted with the 14-3-3 protein, and its association depended on vimentin phosphorylation [48] . The same authors suggested that phosphovimentin, by sequestering 14-3-3 proteins, may limit the availability of this protein to other targets, affecting intracellular signalling processes that required 14-3-3 proteins [48] . Perhaps Bmh2 could also act in the same way, acting as solubility factor of the Fin1 intermediate filament.
3.-Protein phosphatase PP1 interacts physically with Fin1.
It has been recently described (high-throughput two-hybrid analysis; [16] ) that Fin1, fused to the Gal4 DNA binding domain (GBD-Fin1), interacted with Glc7, the catalytic subunit of the PP1 protein phosphatase complex. To confirm these results we repeated the two-hybrid analysis between LexA-Fin1 and GAD-Glc7 (Table III) and confirmed the interaction by pull-down assays in cells expressing GST-Glc7 and HA-Fin1 as fusion proteins (Fig. 3) . We observed that the interaction occurred only between Glc7 and the upper, phosphorylated forms of HA-Fin1. These results might suggest that Glc7 was involved in the regulation of the phosphorylation status of Fin1, either directly or indirectly. A similar situation occurs in mammalian cells where it has been recently described that PP1 protein phosphatase modulates the turnover of phosphorylation and dynamics of desmin/vimentin filaments [49] .
It is known that Glc7 participates in the regulation of different processes by binding to specific regulatory subunits that target the catalytic subunit to the corresponding substrates ( [37] , [50] , [25] , [51] ). As we recovered Reg2 (a regulatory subunit of Glc7) as a Bmh2 interacting protein (see Table I ), we tested if the interaction between Fin1 and Glc7 could be performed in the absence of Reg2. Pull-down assays using a double reg1∆ reg2∆ mutant (Reg1 is another Glc7 regulatory subunit involved in glucose repression [25] ) showed that the interaction between Fin1 and Glc7 was similar to wild type (data not shown). We also studied the phosphorylation status of Fin1 in a partial glc7-1 mutant (the deletion of GLC7 is lethal [52] ), which cannot interact with Gac1, another Glc7 regulatory subunit involved in glycogen metabolism ( [53] , [54] ). As it is shown in Fig. 4, HA-Fin1 showed the same doublet in the mutant as in the wild type. All these results may indicate that neither of these regulatory subunits (Reg1, Reg2 or Gac1) was involved in the binding of Glc7 to Fin1.
Alternatively, Glc7 could interact with Fin1 either directly or via Bmh2. To distinguish between these possibilities we used a bmh1∆ bmh2∆ mutant. It is known that this double mutant is lethal in most genetic backgrounds but it is still viable in the Σ1278b background [10] . We tried to repeat the pull-down experiments in the double mutant but we were unable to recover any viable transformant expressing the GST-Glc7 fusion protein. In an alternative approach to assess the involvement of the 14-3-3 proteins in the regulation of the interaction between Glc7 and Fin1, we decided to analyse the phosphorylation status of Fin1 in the double bmh1bmh2∆ mutant by expressing the HA-Fin1 derivative in these cells. We observed that only the upper, phosphorylated forms of HA-Fin1 were present in the double mutant (Fig. 4) , indicating that in the absence of 14-3-3 proteins Fin1 could not longer be dephosphorylated. LexA-Bmh2 GAD-Fin1 478
LexA-Bmh2 GAD 11
LexA-Fin1 GAD-Fin1 76
LexA-Fin1 GAD <1 Table III : Two-hybrid interaction between Fin1 and Glc7. Two-hybrid interaction between pEG202-Fin1 (LexA-Fin1) and pGAD-Glc7 was measured in CTY10.5d cells. Values for cells growing exponentially in 2% glucose are average β-galactosidase activities of four to six transformants, with standard deviation lower than 15% in all the cases. Please notice that although the interaction between LexA-Fin1 and GAD-Glc7 was low (4 Units), the differences to the controls were statistically significant, indicating a positive interaction between both proteins.
LexA-Fin1 GAD <1 The secondary structure of the Fin1 protein was predicted using the PHDsec programme [55] . H, helix; E, strand. 
